Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gedeon Richter Plc.

http://www.richter.hu

Latest From Gedeon Richter Plc.

Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances

Neuroscience and oncology fuel high hopes for therapeutic R&D progress among 90-plus surveyed biopharma industry leaders.

Scrip Asks Research & Development

AbbVie’s Blockbuster Vraylar Adds Significant Indication, Adjunctive MDD

Already selling at a run rate above $2bn annually, AbbVie predicts the atypical antipsychotic could reach the $4bn mark with a new US indication for adjunctive treatment of major depressive disorder.

Approvals Business Strategies

The Future Is Non-Hormonal: Contraceptive Market Crawls Into The 21st Century

Despite patient dissatisfaction, contraceptive options have made little advancement since the turn of the century – but a cohort of novel, non-hormonal products could see this all change.

Innovation Research & Development

Elucid Brings Personalized Imaging Diagnostics To Cardiology

Elucid has developed machine learning models that can interpret a patient’s risk of stroke or cardiovascular events from angiography images.

Diagnostic Imaging Cardiovascular
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Other Names / Subsidiaries
    • PregLem Holding SA
    • Richter Gedeon Vegyeszeti Gyar Nyrt
    • Richter-Helm BioTec GmbH
    • FINOX Biotech
    • Finox AG
UsernamePublicRestriction

Register